College Community Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 930 F St, Wasco, CA 93280 Phone: 562-467-5440 Fax: 562-467-5553 |
College Community Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 820 6th Street, Wasco, CA 93280 Phone: 661-758-4029 |
Kern Bhrs West Kern Substance Use Disorder Team Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 928 F St, Wasco, CA 93280 Phone: 661-758-7300 |
College Community Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 928 F St, Wasco, CA 93280 Phone: 562-467-5440 Fax: 562-467-5553 |
Kern Bhrs Sud Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1445 Poso Dr, Wasco, CA 93280 Phone: 661-785-7450 |
Kern County Mental Health Department Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 930 F St, Wasco, CA 93280 Phone: 661-758-7300 |
News Archive
Ascendis Pharma A/S, a clinical stage biotechnology company that applies its innovative TransCon technology to address significant unmet medical needs, today announced that it has initiated a Phase 1 single ascending dose study of TransCon Treprostinil in healthy volunteers.
As the novel coronavirus spread across the globe in early 2020, hospitals worldwide scaled back medical procedures, including life-saving heart surgery, to deal with the emerging threat of COVID-19.
Life Technologies Corporation today announced Ion AmpliSeq Community Panels, a community-driven solution to gene panel sequencing that leverages the expertise of scientific thought leaders and the Ion Community to create gene panels for conditions ranging from cancer to inherited diseases.
The New York Times: "About 4,000 Americans - rather than about 1,200 - have died of swine flu since the disease emerged in April, according to new figures being calculated by [CDC] epidemiologists" - an estimate that combines the number of "deaths from laboratory-confirmed cases of the flu and deaths that appear to be brought on by flu, even though the patient may have ultimately died of bacterial pneumonia, other infections or organ failure."
ViroPharma Incorporated today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion at its plenary meeting in March 2011 recommending approval of a Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
› Verified 3 days ago